Total Payments
$7,306
2024 Payments
$2,676
Companies
22
Transactions
430
Medicare Patients
912
Medicare Billing
$481,860
Payment Breakdown by Category
Food & Beverage$7,109 (97.3%)
Education$196.74 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,109 | 427 | 97.3% |
| Education | $196.74 | 3 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,388 | 99 | $0 (2024) |
| ABBVIE INC. | $1,037 | 56 | $0 (2024) |
| UCB, Inc. | $701.89 | 50 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $563.87 | 36 | $0 (2024) |
| Lilly USA, LLC | $539.45 | 32 | $0 (2024) |
| PFIZER INC. | $499.72 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $429.32 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $412.12 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $348.55 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $288.95 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,676 | 156 | Amgen Inc. ($584.83) |
| 2023 | $1,722 | 100 | Amgen Inc. ($417.20) |
| 2022 | $1,645 | 99 | ABBVIE INC. ($310.74) |
| 2021 | $1,263 | 75 | PFIZER INC. ($281.19) |
All Payment Transactions
430 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Immunology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Rheumatology | ||||||
| 12/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: Immunology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Rare Disease | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $9.45 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 548 | 19,472 | $1.5M | $451,530 |
| 2022 | 4 | 272 | 372 | $61,838 | $23,486 |
| 2020 | 4 | 92 | 95 | $90,271 | $6,844 |
Total Patients
912
Total Services
19,939
Medicare Billing
$481,860
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 22 | 8,875 | $710,000 | $298,670 | 42.1% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 16 | 9,300 | $654,000 | $97,482 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 267 | 537 | $105,252 | $37,368 | 35.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 38 | 169 | $22,477 | $6,464 | 28.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 20 | 74 | $20,202 | $5,604 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,848 | $1,583 | 32.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 183 | $8,052 | $1,491 | 18.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 39 | $17,589 | $1,234 | 7.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 12 | 52 | $3,380 | $868.37 | 25.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 34 | 47 | $799.00 | $368.00 | 46.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 29 | 64 | $576.00 | $355.35 | 61.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 28 | 116 | $2,516 | $44.64 | 1.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 229 | 307 | $60,172 | $23,020 | 38.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 27 | $1,188 | $224.59 | 18.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 15 | 17 | $289.00 | $137.36 | 47.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 12 | 21 | $189.00 | $103.89 | 55.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 30 | 31 | $47,337 | $3,914 | 8.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 25 | 25 | $27,898 | $2,017 | 7.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 16 | 18 | $13,482 | $793.90 | 5.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 21 | 21 | $1,554 | $118.74 | 7.6% |
About Emily Langlois, APRN
Emily Langlois, APRN is a Registered Nurse healthcare provider based in Bowling Green, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1922496090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Langlois, APRN has received a total of $7,306 in payments from pharmaceutical and medical device companies, with $2,676 received in 2024. These payments were reported across 430 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($7,109).
As a Medicare-enrolled provider, Langlois has provided services to 912 Medicare beneficiaries, totaling 19,939 services with total Medicare billing of $481,860. Data is available for 3 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family, Nurse Practitioner
- Location Bowling Green, KY
- Active Since 12/24/2014
- Last Updated 02/09/2018
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1922496090
Products in Payments
- Enbrel (Biological) $1,015
- RINVOQ (Biological) $674.43
- Cimzia (Drug) $652.85
- ORENCIA (Biological) $563.87
- TALTZ (Drug) $539.45
- XELJANZ (Drug) $499.72
- TREMFYA (Drug) $391.46
- SAPHNELO (Biological) $348.55
- COSENTYX (Drug) $302.17
- SKYRIZI (Biological) $296.97
- BENLYSTA (Biological) $288.95
- ACTHAR (Biological) $220.34
- STRENSIQ (Biological) $197.60
- COSENTYX (Biological) $127.15
- TAVNEOS (Drug) $122.78
- EVENITY (Biological) $122.72
- LUPKYNIS (Drug) $114.58
- Tymlos (Drug) $90.70
- RENFLEXIS (Drug) $84.46
- KINERET (Drug) $77.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Bowling Green
Jenna Poteet, Aprn, APRN
Registered Nurse — Payments: $10,010
Registered Nurse $10,010
Brittany Jackson, Aprn, Pmhnp-Bc, APRN, PMHNP-BC
Registered Nurse — Payments: $8,114
Registered Nurse $8,114
Mrs. Kristin Lee, Aprn, APRN
Registered Nurse — Payments: $5,886
Registered Nurse $5,886
Malorie Mann, Aprn, Fnp-C, APRN, FNP-C
Registered Nurse — Payments: $1,381
Registered Nurse $1,381
Mrs. Elizabeth Hawkins, Aprn, Cnp, C-Pnp-Pc, APRN, CNP, C-PNP-PC
Registered Nurse — Payments: $1,318
Registered Nurse $1,318
Melody Stanfield, Np, NP
Registered Nurse — Payments: $1,287
Registered Nurse $1,287